Marcus Tablet is indicated for the treatment of several forms of neuropathic pain. It is commonly prescribed in Diabetic Peripheral Neuropathic Pain (DPNP), where long-term diabetes causes nerve damage and painful symptoms in the limbs. It is also used in Postherpetic Neuralgia (PHN), a condition in which pain continues after shingles infection has healed. In addition, Marcus may be prescribed in Peripheral Neuropathic Pain (PNP) and other physician-assessed neuropathic pain conditions where clinical benefit is considered appropriate.Marcus Tablet is indicated for the treatment of several forms of neuropathic pain. It is commonly prescribed in Diabetic Peripheral Neuropathic Pain (DPNP), where long-term diabetes causes nerve damage and painful symptoms in the limbs. It is also used in Postherpetic Neuralgia (PHN), a condition in which pain continues after shingles infection has healed. In addition, Marcus may be prescribed in Peripheral Neuropathic Pain (PNP) and other physician-assessed neuropathic pain conditions where clinical benefit is considered appropriate.

Mirogabalin works by selectively binding to the α2δ subunits of voltage-gated calcium channels located in nerve tissues. Through this action, it helps reduce excessive calcium entry into nerve endings and decreases the release of neurotransmitters involved in abnormal pain transmission. As nerve hypersensitivity is reduced, patients may experience meaningful relief from chronic neuropathic discomfort. This targeted mechanism makes Marcus a valuable therapeutic option for pain conditions associated with damaged or overactive nerves.

Neuropathic pain often remains difficult to manage with standard pain medicines. Marcus Tablet provides a more focused approach by addressing the neurological pathway responsible for pain generation. With physician-guided treatment, it may help reduce pain intensity, improve sleep disrupted by discomfort, support better movement, and enhance the ability to perform everyday activities.

The dose of Marcus Tablet should always be determined by a registered physician according to patient age, clinical condition, symptom severity, kidney function, and treatment response. Therapy is often initiated at a lower dose and gradually adjusted to achieve optimal results while maintaining tolerability. Gradual titration may help minimize unwanted effects and improve overall treatment success. In patients with impaired renal function, dose adjustment may be necessary.

In elderly patients, careful use is advised because dizziness, reduced balance, or drowsiness may increase the risk of falls. During pregnancy, Marcus should be used only when the expected therapeutic benefit outweighs potential risks. For breastfeeding mothers, medical consultation is recommended before use. Safety and efficacy in children and adolescents have not been fully established.

Like many prescription medicines, Marcus Tablet may cause side effects in some individuals. Commonly observed reactions include dizziness, somnolence, fatigue, peripheral swelling, weight gain, blurred vision, or reduced alertness. Many effects are mild to moderate and may improve with physician-guided dose adjustment. If severe drowsiness, confusion, allergic symptoms, persistent vomiting, jaundice, or unusual swelling occurs, prompt medical advice should be sought.

Because Marcus may cause dizziness or sleepiness, caution is recommended while driving, operating machinery, or performing tasks that require full concentration. Patients with kidney impairment should inform their physician before starting treatment. Individuals taking sedative medicines or other central nervous system depressants may require careful monitoring. If blurred vision or double vision appears during treatment, medical review is recommended.

Patients should inform the physician about all prescription medicines, over-the-counter products, herbal preparations, and supplements currently in use. Certain medicines may influence the blood level or effects of Mirogabalin. Alcohol may increase sedation and impairment, therefore caution is strongly advised during therapy.

Marcus Tablet should not be used in individuals with known hypersensitivity to Mirogabalin or to any component of the formulation. Use in other clinically unsuitable situations should be based on physician judgment.

Marcus Tablet should be stored below 30°C in a dry place, protected from direct light and moisture. The medicine should remain in its original packaging and be kept out of reach of children.